Clinical safety · 20 August 2026 · Pathways
The medication history is the weakest link
Pre-operative medication histories are usually assembled from patient recall and a GP summary that may be months old. The drugs patients are least able to name — anticoagulants and SGLT2 inhibitors described as 'a blood thinner' or 'something for sugar' — are precisely the ones whose management must be planned days ahead, which is why they cause cancellations.
“A blood pressure tablet and something for sugar.”
That sentence, or a version of it, is how a large share of pre-operative medication histories are taken. It is not a failure of care and it is not the patient’s fault. It is the predictable output of asking someone to recall, from memory, over the phone, a list of items that look alike, are named unmemorably, and were prescribed by someone else.
The problem is what that sentence conceals. Behind “something for sugar” may sit an SGLT2 inhibitor. Behind an unmentioned item may sit an apixaban. Both require a management plan made days before surgery. Neither will get one.
The drugs most likely to be missed are the ones that matter
There is an unhappy correlation here. The medications whose perioperative management is most time-critical are also among the least likely to be accurately reported.
SGLT2 inhibitors — empagliflozin, dapagliflozin, ertugliflozin — carry a risk of euglycaemic diabetic ketoacidosis, a presentation in which ketoacidosis develops with a normal or near-normal blood glucose. The diagnostic signal clinicians are trained to look for is absent. Withholding has to begin days ahead. And patients almost never name the drug, because to them it is one of the diabetes tablets.
Anticoagulants are the same shape. The withholding interval depends on the specific agent, the bleeding risk of the procedure, and renal function — none of which can be worked out for a drug nobody knows the patient is taking. “A blood thinner” is not enough to plan from, and a patient who has been on the same tablet for three years may not think to mention it at all.
Why the referral letter does not close the gap
The obvious answer is to take the medication list from the record rather than the patient. In practice the record has its own failure mode: it is a snapshot, and it ages.
A GP summary written eight months ago predates any prescribing change since. A referral letter reflects the referrer’s view at the time of referral, which may itself have been copied from something older. Neither is wrong, exactly. Both are stale in a way that is invisible — a list with no gaps looks complete whether or not it is current.
So the two available sources fail differently and, importantly, they fail independently. Patient recall misses drugs the record has. The record misses drugs the patient has started since. Reconciling them requires actually comparing them, which is work, and which is why it is usually skipped in favour of trusting whichever one is to hand.
Verification, not collection
The useful reframing is that this is not a collection problem. Adding another place to write the medication list does not help if every source is reconstructed from the same unreliable memory.
It is a verification problem. What changes the reliability of the list is having the patient photograph the boxes.
This sounds mundane and is the substantive shift. A photograph of a medication box is primary evidence: the drug name and strength are printed on it. It does not depend on the patient knowing what the drug is or why they take it — only on their being able to find the box, which almost everyone can. It works for handwritten pharmacy labels and for the patient who brings six boxes and describes none of them.
Three properties follow from working off images rather than recall:
- Extraction can be checked against its source. Every value is verified against the image before it enters the record, rather than transcribed and trusted.
- Uncertainty becomes visible. A value read at 0.97 confidence and one read at 0.62 are not presented identically. What was hard to read is flagged for human review rather than smoothed over.
- Conflicts surface rather than resolving silently. A drug in the photos and absent from the referral history is a finding, not a discrepancy to be quietly reconciled in favour of whichever source was consulted last.
That last one is the case worth dwelling on. The staged example in the product shows exactly it: an apixaban extracted from a box photo, checked against a GP summary eight months old, absent from it, and flagged. Under recall-based history-taking that patient has no anticoagulant. Under photograph-based verification they have one, and the discrepancy is the thing the clinician is shown.
What this is worth
Reliable medication data is not an end in itself. It is the input on which the time-critical decisions depend — and those decisions have a deadline that arrives well before the day of surgery.
An SGLT2 inhibitor identified nineteen days out is a withholding plan. The same drug identified at 07:00 on the morning of surgery is a cancellation, because no decision available that morning can undo the last dose.
The difference between those two outcomes is not clinical judgement. It is whether anyone knew.